glp-1

Symptoms & treatment

Peptide News This Week: The FDA's Big BPC-157 Vote, a 22.6% Weight-Loss Result, and What It All Means for Your Midlife Health

An FDA panel voted to allow BPC-157 back in compounding pharmacies, and retatrutide hit 22.6% weight loss. Here is what this week's peptide news means for your midlife health.